TrialLung cancer (Amsterdam, Netherlands)2018

Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study.

Shirish M Gadgeel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.